Drossopoulou GI, Tsotakos NE, Tsilibary EC. Impaired transcription factor interplay in addition to advanced glycation end products suppress podocalyxin expression in high glucose-treated human podocytes. Am J Physiol Renal Physiol 297: F594 -F603, 2009. First published July 15, 2009 doi:10.1152/ajprenal.00203.2009.-Podocalyxin represents a Wilms' tumor suppressor protein (WT1)-regulated differentiation marker for glomerular epithelium. We provide evidence concerning mechanisms involved in the regulation of podocalyxin expression following long-term exposure to increased (25 mM) glucose levels. Prolonged culture of conditionally immortalized human podocytes in 25 mM glucose induced suppression of podocalyxin expression both at the protein and mRNA levels, whereas WT1 protein levels remained unaltered. WT1 interacted with another transcription factor, CRE-binding protein (CBP). This association was decreased by 40% in the presence of 25 mM glucose. Chromatin immunoprecipitation assays on chromatin from podocytes cultured in 25 mM glucose revealed reduced WT1 binding to podocalyxin promoter sequences, probably resulting from impaired WT1-CBP interactions. We explored the possible role of glucose-induced adducts (advanced glycation end products; AGEs) in impairing interactions between WT1 and CBP, with the use of aminoguanindine, an inhibitor of AGE formation. Podocytes were cultured in the simultaneous presence of 20 mM aminoguanidine and 25 mM glucose, and podocalyxin protein levels were examined. Aminoguanidine effectively prevented downregulation of podocalyxin protein levels but could not restore podocalyxin levels once expression was suppressed. Thus increased glucose apparently impaired the ability of WT1 to initiate transcription in part by decreased association of WT1 with CBP.
The expression of PC in the developing kidney is regulated by Wilms' tumor suppressor protein (WT1) (26) , and additional reports indicate that transcriptional regulation of PC is also supported by Sp1 binding site(s) (2) . The binding of WT1 to conserved elements within the PC gene promoter results in potent transcriptional activation (26) . Mouse models have shown that disruption of the WT1 gene can result in the development of glomerular sclerosis (24) . The molecular effects of high glucose on podocytes have not been yet fully elucidated, and there are questions regarding the role of WT1 in kidney function. Several partners have been described for WT1 (29) . It is likely that they provide specificity to WT1 function and determine whether WT1 acts as a transcriptional activator or repressor. A novel WT1-interacting protein (WTIP) was identified (31) , which was suggested to monitor slit diaphragm protein assembly as part of a multiple-protein complex (28) . According to this hypothesis, WTIP acts as a transcriptional corepressor for WT1 (28) . Furthermore, brain acid soluble protein 1 has been previously identified as another WT1 transcriptional cosuppressor (3) . The binding of WT1 to conserved elements within the PC gene promoter seems to be relevant for renal development, but molecular mechanisms explaining maintenance of PC expression in adult podocytes have not been deciphered as yet. In view of these facts, we have used an in vitro model system of T-SV40 immortalized human glomerular epithelial cells (HGEC) that display all the relevant podocyte markers, structurally resemble podocytes by developing footlike processes when grown on laminin or glomerular basement membrane (10) , and have already been used for expression and functional studies (6, 10, 20, 22) .
HGEC permanently cultured in the presence of high glucose express very low PC protein levels compared with HGEC permanently cultured in normal glucose (10) . Cre-binding protein (CBP) is a coactivator known to enhance CRE site-dependent transcriptional activation by CRE-binding factors. WT1 binds to CBP, and this protein interaction contributes to WT1-dependent transcriptional activation (38) . Disruption of WT1-CBP interaction suppresses the transcriptional activation of endogenous target genes by WT1 (38) . Transcriptional activation by WT1 may therefore be specifically inhibited by disruption of its interaction with endogenous CBP. In view of these facts, we investigated WT1's association with CBP. Our results indicate that chronic exposure to high glucose levels resulted in extended, severe suppression of PC expression. WT1 and CBP were coimmunoprecipitated from cellular lysates, indicating that they were associated; this association may modulate the transactivational properties of each other. Disruption of the interaction of WT1 with endogenous CBP inhibited transcriptional activation by WT1.
Other effects of high glucose include increased protein glycation/nonenzymatic glucosylation, which alters their structure and function in vitro (13, 36) . Nonenzymatic glucosylation reactions result in the formation of a class of heterogeneous compounds referred to as advanced glycation end products (AGEs) (34) . We investigated whether increased, glucoseinduced accumulation of AGEs also contributes to the suppression of PC expression in the presence of diabetic glucose levels. We provide herein evidence for the first time that AGE inhibition preserved PC gene expression even in the presence of increased/"diabetic" glucose levels.
MATERIALS AND METHODS
Cell line and culture conditions. Immortalized T-SV40 HGEC were cultured in the presence of 5 or 25 mM glucose as previously described (10) . Cells were released from their tissue culture flasks for passaging by treatment with 0.05% trypsin/0.03% EDTA when they reached 80% confluency.
Reverting glucose concentrations. Immortalized T-SV40 HGEC cultured in the presence of 5 mM glucose were stored in liquid nitrogen at passage 2 (P2). Subsequently, these cells were used to examine whether the expression levels of PC can be reduced by continuously growing them in the presence of 25 mM glucose. Routinely, 4 ϫ 10 5 cells were plated in 75-cm 2 flasks and were allowed to attach and grow up to 80% confluency (ϳ1 wk). During this period, the culture medium was changed every 48 h, with fresh culture medium containing 25 mM glucose. This procedure was repeated for up to 18 wk. Every 2 wk, a batch of cells was stored in liquid nitrogen. After completion of the relevant week, cells were released from their tissue culture flask and subsequently used for each experiment. In some experiments, the culture medium was changed with fresh culture medium (every 48 h) containing 25 mM glucose and 20 mM aminoguanidine (AG).
Immortalized T-SV40 HGEC cultured in the presence of 25 mM glucose were stored in liquid nitrogen at passage 4 (P4). Subsequently, these cells were used to examine whether the expression levels of PC can be restored by continuously growing them in the presence of 5 mM glucose. Routinely, 5 ϫ 10 5 cells were plated in 75-cm 2 flasks and were allowed to attach and grow up to 80% confluency (ϳ1 wk). During this period, the culture medium was changed every 48 h, with fresh culture medium containing 5 mM glucose. This procedure was repeated for several weeks. Every 2 wk, a batch of cells was stored in liquid nitrogen. After completion of the relevant week, cells were released from their tissue culture flask and subsequently used for each experiment.
Materials. Rabbit polyclonal antibodies against WT-1 (WT1 C-19) and CBP (CBP A-22), as well as a mouse monoclonal antibody against Sp1 (Sp1 1C6) and goat polyclonal antibody against nephrin (nephrin N-20), were purchased from Santa Cruz Biotechnology. A mouse monoclonal antibody for WT-1 (MAB4234) was purchased from Upstate. A mouse monoclonal anti-human integrin-␤1 antibody (MAB1959) was purchased from Chemicon. A rabbit polyclonal antibody against zonula occludens-1 (ZO-1) was purchased from Zymed Laboratories (Invitrogen 61-7300). A mouse monoclonal antibody against the extracellular domain of human PC (3D3) was a kind gift of Dr. D. B. Kershaw. A mouse monoclonal antibody against ␤-tubulin was purchased from Sigma. Anti-nephrin blocking peptide was purchased from Santa Cruz Biotechnology (sc19000P).
Western blotting. Cultured cells were released by trypsin treatment and lysed in modified buffer as described previously (10) . The lysates were cleared from aggregated material by centrifugation at 10,000 g for 30 min at 4°C. Protein estimation was performed by a Bradford colorimetric assay (Pierce). For Western blot analysis, 50 g of proteins from cell lysates were run on 7.5% SDS-PAGE. Proteins were then transferred to Hybond-ECL nitrocellulose membrane (Amersham) for immunoblotting according to previously described procedures (10) . To ensure equal amounts of protein loading, the blots were stripped (Re-Blot Plus Western Blot Stripping Solution, Chemicon) and reprobed with an anti-␤-tubulin monoclonal antibody (1:500 dilution). For detection of human PC, membranes were labeled with an antibody against human PC (3D3) at 1:20 dilution. For detection of WT1, membranes were labeled with an antibody against WT1 (C-19) at 1:500 dilution. For detection of CBP, membranes were labeled with an antibody against CBP (A-22) at 1:1,000 dilution. For detection of Sp1, membranes were labeled with an antibody against Sp1 (1C6) at 1:2,000 dilution. For detection of ZO-1, membranes were labeled with an antibody against ZO-1 (Invitrogen 61-7300) at 1:1,000 dilution. For detection of nephrin, membranes were labeled with an antibody against nephrin (N-20) at 1:100 dilution. All incubations were performed at 4°C overnight. In selected experiments, the anti-nephrin polyclonal antibody N-20 was preincubated with a blocking peptide (1:5 ratio, antibody to peptide) for 3 h at room temperature before membrane labeling.
Isolation of nuclear extracts. Nuclear protein extracts were obtained as described (11) . For the preparation of cytoplasmic and nuclear cell extracts, HGEC grown on 75-cm 2 flasks were quickly chilled in ice-cold PBS. The cells were scraped off and solubilized in buffer A (20 mM HEPES, pH 7.9, 10 mM KCl, 1 mM EDTA, 1 mM DTT, 1 mM phenylmethylsulfonyl fluoride, 0.1 mM NaO 3VO4, 0.2% Nonidet P-40, 10% glycerol, and protease inhibitors). Cell lysates were centrifuged at 13,000 rpm for 5 min. The supernatants were recovered and considered as cytoplasmic extracts. The pellets were extracted with buffer B (20 mM HEPES, pH 7.9, 350 mM NaCl, 10 mM KCl, 1 mM EDTA, 1 mM DTT, 1 mM phenylmethylsulfonyl fluoride, 0.1 mM NaO3VO4, 20% glycerol, and protease inhibitors) with 100 l of buffer B for 8 ϫ 10 6 cells. After three cycles of freezing in liquid nitrogen and thawing, extracts were centrifuged at 10,000 rpm for 15 min. The supernatants were quickly frozen and stored at Ϫ70°C and considered as nuclear extracts.
Protein estimation was performed by a Bradford colorimetric assay (Pierce) only on the cytoplasmic cell extracts. Nuclear proteins were separated by 7.5% SDS-PAGE and transferred to Hybond-ECL nitrocellulose membrane (Amersham) for immunoblotting. To ensure equal amounts of protein loading, the blots were stripped (Re-Blot Plus Western Blot Stripping Solution, Chemicon) and reprobed with an anti-␤-tubulin monoclonal antibody.
Coimmunoprecipitation studies. In one series of experiments, HGEC lysates were prepared as mentioned before and were subsequently incubated overnight, at 4°C with 2 g of an antibody against WT1 (mouse anti-human WT1, Upstate) per 400 g of total protein. Sepharose beads were subsequently added. Bound immune complexes were eluted by incubating the beads in Laemmli sample buffer at 95°C for 5 min and separated by SDS-PAGE followed by immunoblotting. For CBP detection, a rabbit anti-human CBP antibody (A-22) was used at 1:400 dilution. Blots were also probed with an anti-WT1 antibody (rabbit anti-human WT1 C-19) at 1:500 dilution to verify immunoprecipitation loads against which the data were normalized.
In another series of experiments, HGEC lysates were prepared as mentioned above and were subsequently incubated overnight, at 4°C, with 2 g of an antibody against CBP (rabbit anti-human CBP Santa Cruz Biotechnology) per 400 g of total protein. Sepharose beads were subsequently added. Bound immune complexes were eluted by incubating the beads in Laemmli sample buffer at 95°C for 5 min and separated by SDS-PAGE followed by immunoblotting. For WT1 detection, mouse anti-human WT1 (Upstate) was used at 1:200 dilution. Blots were also probed with an anti-CBP antibody (rabbit anti-human CBP A-22) at 1:400 dilution to verify immunoprecipitation loads against which the data were normalized.
Cross-linking and immunoprecipitation of chromatin. The formaldehyde cross-linking and immunoprecipitation protocol was adapted from Refs. 4 and 5 with modifications. Samples were sonicated with an Ultrasonics sonicator at full power for three 30-s pulses on ice to an average length of 200 -500 bp and then microcentrifuged at 14,000 rpm. Chromatin was incubated with 1 g of an affinity-purified rabbit polyclonal antibody (WT1 C-19, sc-192X, Santa Cruz Biotechnology) or 1 g of an anti-human RNA polymerase antibody (Upstate) or no antibody and rotated at 4°C for 12 h. Immunoprecipitation, washing, and elution of immune complexes were carried out as described previously (4, 5) . One-half of the supernatant from the no-primary-antibody reaction for each time point was saved as 50% total input chromatin and was processed with the eluted immunoprecipitates. Pellets were collected by microcentrifugation, resuspended in 30 l of H 2O, and analyzed by PCR. The following primer pairs were used; PC promoter region 5Ј-TTAATAGATTGGCACAGTTAGG-3Ј (forward primer) and 5Ј-GAGAGAAGTTTGGAGAAATACC-3Ј (reverse primer); and endogenous GAPDH 5Ј-TGACTAGCGGT-ACCGGGGTTGCTGCTGTGGAACC-3Ј(forward primer) and 5Ј-CGGGCTTGCTTACCCACCTTCCCCAGCAGTCGACAC-3Ј (reverse primer). Following 40 cycles of amplification, PCR products were run on a 2% agarose gel and analyzed by ethidium bromide (EtBr) staining.
Quantitative real-time RT-PCR analysis. Total RNA was isolated with the SV Total RNA Isolation System (Promega). Reverse transcription of 3 g total RNA was performed using the ImProm-II reverse transcriptase system (Promega). Primers were designed with the Beacon Designer 7.01 version as follows: PC (5Ј-AATTCCTTTCCCAGTTGT-3Ј and 5Ј-TTCTCAGTAAAT-TCCAGTGTA-3Ј); GAPDH (5Ј-CCAAAATCAAGTGGGGC-GATG-3Ј and 5Ј AAAGGTGGAGGAGTGGGTGTCG-3Ј); ZO-1 (5Ј-TGAAAAATGGCTTCGGGGCAAG-3Ј and 5Ј-TCTCAAA-CGGCTGGTGGCAATC-3Ј); and nephrin (5Ј-AGTTCTGCCACCCTC-CAC-3Ј and 5Ј-GCTGATGCTGACAAGTTGAATG-3Ј). Forward and reverse primers were used at final concentrations of 100 nM for PODXL, ZO-1, and nephrin and 50 nM for GAPDH. Quantitative real-time RT-PCR was then performed using the Brilliant SYBR Green QPCR Master Mix system (Stratagene) in a MX3000P cycler (Stratagene) under the following conditions: 95°C for 15 min, 94°C for 30 s, 58°C for 30 s, and 72°C for 30 s (50 cycles). GAPDH was used as an internal control normalizing genes. mRNA levels were determined by the efficiency-corrected ⌬⌬Ct comparative quantification method using the comparative quantitation module of MxPro software (Stratagene). The specificity of product amplification was determined by melting curve profiling (cooling to 55°C and slowly heating to 95°C with continuous measurement of fluorescence).
Statistical analysis. Results are expressed as means Ϯ SE. Mean values were derived from experiments performed at least three times as described in the text. Single-factor ANOVA was used to evaluate the results of Western blotting, real-time RT-PCR, coimmunoprecipitation assays, and chromatin immunoprecipitation (IP; ChIP) assays. Additionally, post hoc testing using the Newman-Keuls test was used to compare the differences between the selected pairs of means. In all instances, P Ͻ 0.05 was considered statistically significant.
RESULTS

Suppression of PC expression in HGEC.
HGEC permanently cultured in the presence of 5 mM glucose express PC (Fig. 1A , lane 1) but begin exhibiting downregulated PC levels following 2 wk of culturing in the presence of 25 mM glucose. Severely reduced PC expression (both at the protein and mRNA level) was observed following 14 wk of culture in the continuous presence of 25 mM glucose (Figs. 1A, lane 4, and  C) . Furthermore, to examine whether restoration of normal PC expression levels is a similarly slow process, we exposed HGEC not expressing PC to normal glucose levels (5 mM). Immunoblotting and quantitative real-time PCR analysis demonstrated that after 12 wk of culturing in 5 mM glucose, the expression levels of PC could not be fully restored (Figs. 1A,  lane 3, and C) . Therefore, restoration of normal PC levels is a prolonged process.
Reduced PC expression in the presence of 25 mM glucose is not a consequence of reduced WT1 protein levels. It has been reported that WT1 is a shuttling protein and that a significant fraction of endogenous WT1 is cytoplasmic (31) . These reports prompted us to investigate the intracellular distribution of this protein in HGEC. Western blot analysis of nuclear and cytoplasmic fractions prepared from HGEC cultured in 5 or 25 mM glucose levels revealed that WT1 is predominantly nuclear, as detected by the C19 antibody ( Fig. 2A, B) . Both cytoplasmic fractions were positive for WT1 as well ( Fig. 2A, lanes 2 and glucose. Lane 3, PC expression in HGEC continuously exposed to 25 mM and reverted to 5 mM glucose for 12 wk; lane 4, HGEC continuously exposed to 5 mM glucose and reverted to 25 mM for 14 wk. Equal amounts of total protein were analyzed by SDS-PAGE and immunoblotted with an anti-PC antibody. Blots were reprobed with an anti-tubulin antibody to verify protein loads against which the data were normalized. B: values are means Ϯ SD of 4 independent experiments and analyzed by densitometric analysis using singlefactor ANOVA. Reduction of PC protein levels by HGEC cultured in the presence of 25 mM glucose was statistically significant compared with control cells White bars, HGEC exposed to 5 mM glucose; shaded bars, HGEC exposed to 25 mM glucose. ***P Ͻ 0.001, **P Ͻ 0.002 by ANOVA. C: real-time PCR analysis for PC expression in HGEC. PC expression was measured in HGEC continuously exposed to 5 mM glucose, continuously exposed to 25 mM glucose, continuously exposed to 25 mM and reverted to 5 mM for 12 wk, and continuously exposed to 5 mM and reverted to 25 mM glucose for 14 wk, respectively. GAPDH was used as the normalizer gene. Values are means Ϯ SD of 4 quadruplicate experiments. White bars, HGEC exposed to 5 mM glucose; shaded bars, HGEC exposed to 25 mM glucose. ***P Ͻ 0.001, *P Ͻ 0.05 by ANOVA.
4).
A comparison with a series of nuclear dilutions revealed that the proportion of cytoplasmic WT1 was about one-eighth of the total cellular WT1 (Fig. 2, A and B) . However, no significant differences in the nuclear protein levels of WT1 were observed in the two conditions, excluding WT1 as a potential target for the observed defect ( Fig. 2A, lanes 1 and 3,  and B) .
Reduced PC expression in the presence of 25 mM glucose is not a consequence of reduced Sp1 protein levels. The human PC gene and 250 bp upstream of the putative start methionine was previously cloned and mapped to chromosome 7q32-q33 (18) . The PC promoter shows a progressively increasing number of Sp1 sites (2), which were essential for maintaining PC transcription (2) . Western blot analysis of nuclear and cytoplasmic fractions prepared from HGEC continuously cultured in the presence of 5 or 25 mM glucose levels revealed that Sp1 is detected in both nuclear and cytoplasmic fractions. The proportion of nuclear Sp1 was about two-thirds of the total cellular Sp1 (Fig. 2, C and D) . Despite differences in the endogenous content of PC, both nuclear and cytoplasmic levels of Sp1 in HGEC cultured in 5 or 25 mM glucose were not significantly different. (Fig. 2, C and D) .
The binding of WT1 to CBP becomes impaired in the presence of high glucose. High-affinity WT1 binding sites have been identified on the PC promoter region (23, 26) . WT1 binds CBP, and this protein interaction contributes to WT1-dependent transcriptional activation (38) . Since CBP can alter transcriptional regulation by WT1 we examined WT1 interactions with CBP, in HGEC cultured in 5 or 25 mM glucose. Expression of WT1 and CBP in these cells was detectable by immunoblotting in nuclear and cytoplasmic fractions (Fig. 2, A, C,  and D) . Extraction of HGEC cellular lysates followed by immunoprecipitation with an antibody against the COOH terminus of WT1 (C19) and immunoblotting using an anti-CBP antibody demonstrated coimmunoprecipitation of these two proteins (Fig. 3A) . Similarly, immunoprecipitation of lysates with an anti-CBP antibody, followed by immunoblotting with an anti-WT1 antibody showed coprecipitation of WT1 with endogenous CBP (Fig. 3D) . Comparison of the amounts of coprecipitated WT1 or CBP with the total cellular proteins directly immunoprecipitated from lysates indicated that ϳ10% of cellular CBP coprecipitated with WT1 in HGEC cultured in 5 mM glucose, but in HGEC cultured 25 mM glucose only 6% of CBP coprecipitated with WT1. Therefore, the association between WT1 and CBP was reduced by 40% in HGEC cultured in 25 mM glucose levels compared with 5 mM (normal) glucose (Fig. 3, A, B, D, and E) .
WT1 binds to the PC promoter, an interaction which becomes impaired in the presence of high glucose. To determine whether WT1 binds directly to the PC promoter, we utilized ChIP assays. HGEC cultured in 5 mM glucose (Fig. 4B) showed that the PC promoter sequence was specifically enriched by IP with an anti-WT1 antibody compared with IP with mouse IgG. This enrichment was confirmed using PCR analysis. DNA recovered from ChIP reactions was amplified using the PCR primers specific for the PC promoter. The PC promoter product was detected in the anti-WT1 ChIP reaction, indicating enrichment of PC promoter DNA by anti-WT1 3) and cytoplasmic (lanes 2 and 4) protein fractions were extracted from HGEC. Lanes 1 and 2, WT1 expression in HGEC cultured in 5 mM glucose; lanes 3 and 4, WT1 expression in HGEC cultured in 25 mM glucose. Equal amounts of protein extracts were analyzed on 7.5% SDS-PAGE under reducing conditions and immunoblotted with an anti-WT1 antibody (WT-1 C-19). Blots were stripped and reprobed with an anti-tubulin antibody to verify protein loads against which the data were normalized. B: quantitation of the protein content by densitometric analysis. Values are means Ϯ SD of 5 independent experiments analyzed using single-factor ANOVA. Nuclear WT1 protein levels were significantly higher compared with cytoplasmic WT1 protein levels. White bars, HGEC exposed to 5 mM glucose; shaded bars, HGEC exposed to 25 mM glucose. **P Ͻ 0.02 by ANOVA. C: Western blot for Cre-binding protein (CBP) and Sp1 expression in HGEC. Nuclear (lanes 1 and 3) and cytoplasmic (lanes 2 and 4) protein fractions were extracted from HGEC. Lanes 1 and 2, CBP and Sp1 expression in HGEC continuously cultured in 5 mM glucose; lanes 3 and 4, CBP and Sp1 expression in HGEC continuously cultured in 25 mM glucose. Equal amounts of protein extracts were analyzed on 7.5% SDS-PAGE under reducing conditions and immunoblotted with an anti-CBP antibody (CBP A-22) and anti-Sp1 antibody (Sp1 1C6). Blots were stripped and reprobed with an anti-tubulin antibody to verify protein loads against which the data were normalized. D: quantitation of the protein content by densitometric analysis. Values are means Ϯ SD of 3 independent experiments analyzed using single-factor ANOVA. Nuclear CBP and Sp1 protein levels were significantly higher compared with the respective cytoplasmic CBP and Sp1 protein levels. White bars, HGEC exposed to 5 mM glucose; shaded bars, HGEC exposed to 25 mM glucose. *P Ͻ 0.05 by ANOVA.
ChIP. Together, these results indicate that the WT1 protein is associated with the endogenous PC promoter in actively growing HGEC in 5 mM glucose (Fig. 4B) . ChIP carried out using formaldehyde-cross-linked chromatin from HGEC cultured in 25 mM glucose (Fig. 4A) showed that the PC promoter sequence was also specifically enriched by IP with anti-WT1, but the PC promoter product which was detected in this anti-WT1 ChIP reaction was significantly lower than that of the ChIP reaction from HGEC cultured in 5 mM glucose (Fig. 4B) . Thus ChIP assays indicated that decreased WT1-CBP association leads to decreased binding of WT1 to the PC promoter, disrupting transcriptional activation of target genes by WT1.
In vitro culturing of HGEC in the presence of high glucose levels resulted in reversible downregulation of ZO-1 mRNA and protein expression. ZO-1, a protein of podocytic tight junctions in vivo, also localizes to the cytoplasmic side of filtration slits. In these sites, ZO-1 was shown to colocalize with P-cadherin and interact with Neph1 (14), a slit diaphragm protein of the immunoglobulin superfamily, with a PDZbinding site. To determine whether the observed suppression of gene expression was specific to PC, we investigated ZO-1 expression levels under the same conditions. Western blot analysis demonstrated that ZO-1 expression in non-PCexpressing HGEC could be significantly restored after 12 Fig. 3 . Cross-immunoprecipitation Western blot analysis of HGEC. A: equal amounts of cellular lysates from HGEC cultured in the presence of 5 or 25 mM glucose were immunoprecipitated using an anti-WT1 antibody (mouse anti-human WT1, Upstate) followed by immunoblotting analysis using an antibody to CBP (rabbit anti-human CBP, Santa Cruz Biotechnology). Blots were also probed with an anti-WT1 antibody (rabbit anti-human WT1, Santa Cruz Biotechnology) to verify immunoprecipitation loads against which the data were normalized. B: quantitation of the protein content of CBP and WT1 by densitometric analysis. Values are means Ϯ SD of 7 independent experiments. Open bar, HGEC exposed to 5 mM glucose; filled bar, HGEC exposed to 25 mM glucose. *P Ͻ 0.05 by ANOVA. C: negative controls. Equal amounts of cellular lysates from HGEC cultured in the continuous presence of 5 or 25 mM glucose were also immunoprecipitated (IP) using an anti-WT1 antibody (mouse anti-human WT1 Upstate), no antibody, and anti-integrin ␤1 (mouse anti-human integrin-␤1, the last 2 being the negative controls), followed by immunoblotting analysis using an anti-WT1 antibody (rabbit anti-human WT1, Santa Cruz Biotechnology). D: equal amounts of cellular lysates from HGEC cultured in the presence of 5 or 25 mM glucose were immunoprecipitated using an anti-CBP antibody (rabbit anti-human CBP Santa-Cruz) followed by immunoblotting analysis using an antibody to WT1 (mouse anti-human WT1 Upstate). Blots were also probed with an anti-CBP antibody (rabbit anti-human CBP, Santa Cruz Biotechnology) to verify immunoprecipitation loads against which the data were normalized. E: quantitation of the protein content of CBP and WT1 by densitometric analysis. Values are means Ϯ SD of 7 independent experiments. White bar, HGEC exposed to 5 mM glucose; filled bar, HGEC exposed to 25 mM glucose. *P Ͻ 0.05 by ANOVA. F: negative controls. Equal amounts of cellular lysates from HGEC cultured in the continuous presence of 5 or 25 mM glucose were also immunoprecipitated using an anti-CBP antibody (rabbit anti-human CBP Santa Cruz Biotechnology), no antibody, and anti-integrin-␤1 (mouse anti-human integrin-␤1, the last 2 being the negative controls), followed by immunoblotting analysis using an anti-CBP antibody (rabbit anti-human CBP, Santa Cruz Biotechnology).
wk of culturing in 5 mM glucose (Fig. 5, A and B) . Furthermore, quantitative real-time PCR analysis revealed that ZO-1 mRNA expression in HGEC not expressing PC was reduced by ϳ50% (Fig. 5C ). Normal mRNA and protein expression levels were restored after 12 wk of culturing in 5 mM glucose (Fig. 5C) .
In vitro culturing of HGEC in high glucose results in suppression of nephrin expression. In addition to the binding of WT1 to the PC promoter, WT1 can bind and activate the nephrin promoter and this binding is essential for podocytespecific nephrin expression in vivo (37) . To determine whether the observed suppression of PC gene expression also occurs in other WT1 targets, we investigated the expression of nephrin under the same conditions. In our model system, nephrin expression (both at the protein and mRNA levels) in HGEC not expressing PC was severely reduced. Furthermore, it also seems that restoration of nephrin expression also requires some time, since normal nephrin expression levels were not established in the time course of our experiments (Fig. 6, A-C) .
Long-term administration of AG prevented glucose-induced "silencing" of PC expression. We examined whether the observed glucose-induced PC suppression (Fig. 7D, lanes 3-5, and E, shaded bars) could also be due to the formation of AGEs within the cytoplasm, at least in part. AG, which prevents formation of AGEs, was shown to improve nephropathy, retinopathy, and vessel elasticity when administered to diabetic rats (1, 35) . We cultured HGEC-expressing PC in the concomitant presence of 20 mM AG and 25 mM glucose and examined PC expression by immunoblotting. In these experiments, AGmediated inhibition of AGEs resulted in maintenance of PC expression (Fig. 7C, lanes 2, 3, 6, and 7, and E, black bars) . AG alone did not alter the levels of PC expression in HGEC continuously exposed to 5 mM glucose (Fig. 7, A and B, black  bars) .
Glucose-induced suppression of PC expression was not prevented by late addition of AG. In additional experiments, we examined whether AG could restore PC expression in cells which already had suppressed PC expression as a result of high glucose: HGEC cultured in the presence of 25 mM glucose for 16 wk were subsequently exposed to 20 mM AG in the culture medium. The cells were further cultured for an additional 2 wk in the presence of 25 mM glucose and 20 mM AG. AG added after suppression of PC did not restore its expression (Fig. 7C, lane 5) . expression in HGEC continuously exposed to 25mM and reverted to 5mM glucose for 12 wk. Equal amounts of total protein were analyzed on 7.5% SDS-PAGE under reducing conditions and immunoblotted with an anti-ZO-1 antibody (Zymed Laboratories). Blots were stripped and reprobed with an anti-tubulin antibody to verify protein loads against which the data were normalized. B: quantitation of ZO-1 protein content by densitometric analysis. Values are means Ϯ SD of 4 independent experiments analyzed using singlefactor ANOVA. White bars, HGEC exposed to 5 mM glucose; shaded bars, HGEC exposed to 25 mM glucose. Reduction of ZO-1 in HGEC cultured in the presence of 25 mM glucose was statistically significant compared with control cells. *P Ͻ 0.05 by ANOVA. C: real-time PCR analysis for ZO-1 in HGEC. ZO-1 expression was measured in HGEC continuously exposed to 5 and 25 mM glucose and to 25 mM then reverted to 5 mM for 12 wk. GAPDH was used as the normalizer gene. Values are means Ϯ SD of 3 duplicate experiments. White bars, HGEC exposed to 5 mM glucose; shaded bars, HGEC exposed to 25 mM glucose. *P Ͻ 0.05 by ANOVA. Fig. 4 . WT1 binds specifically to the PC promoter region. HGEC continuously exposed to 5 or 25 mM glucose were cross-linked with formaldehyde. Cross-linked chromatin from each condition was prepared and immunoprecipitated with an antibody against WT1 (␣-WT1), antibody against RNA polymerase II [anti-RNA polymerase II (clone CTD448; ␣-RNApol)], and antibody against mouse IgG (␣-mIgG). A: ethidium bromide-stained gel showing the size of DNA fragments following sonication. Lanes were loaded with 2.5% input chromatin from the specified condition after reversal of the cross links and proteinase K treatment. DNA size markers are as indicated. B: PCR analysis of immunoprecipitation reactions with PC and GAPDH promoter primers to amplify the endogenous PC and GAPDH promoter regions. For all conditions, immunoprecipitates were resuspended in 30 l of H2O and input chromatin samples were diluted to 2% in 100 l H2O. PCR products were electrophoresed on a 2% agarose gel and stained with ethidium bromide. (The assay was repeated 2 more times. This figure represents results from 1 complete assay).
DISCUSSION
We addressed several mechanisms involved in the regulation and maintenance of PC expression, using an in vitro model system of PC-expressing and PC-non-expressing podocytes. Apparently, the cells used express WT1, a marker of glomerular epithelial cells, in the presence or absence of increased glucose concentrations. We conclude that high glucose resulted in impairment of the ability of WT1 to initiate transcription, in part due to the decreased association of WT1 with CBP. Dominant negative construct reporter assays, using the domain that mediates interaction of CBP with WT1, indicated that the observed reduction in WT1-mediated gene activation is dose dependent (38) . Hence, reduction of WT1-CBP interaction could be pivotal for suppression of PC expression, resulting in the observed impaired binding of WT1 to the PC promoter, after long-term exposure to 25 mM glucose. Furthermore, AG was able to prevent suppression of PC expression, indicating that loss of PC was due, at least in part, to the formation of AGEs in the presence of high glucose.
In diabetic nephropathy, foot processes become eventually effaced as a result of high glucose (25) , while a glucoseinduced decrease in PC expression was confirmed by immunohistochemistry in the glomeruli of streptozotocin-diabetic rats (10, 33) and kidney biopsies from patients with diabetic nephropathy (21) . Therefore, unraveling mechanisms of decreased PC gene expression is pivotal for understanding its functional role. Effacement of foot processes is also observed in Denys-Drash syndrome (40) , in which both WT1 and PC levels are decreased, thus linking WT1 with PC expression. In contrast to previous reports, our finding that glucose-induced loss of PC is not accompanied by reduced WT1 protein levels, suggests that in our system, WT1 alone does not suffice to maintain PC expression. Apparently, an interplay with other transcription factors such as CBP is important for this function. The levels of Sp1, a transcription factor for which multiple binding sites exist on the PC promoter (2), were not significantly affected by high glucose; thus this transcription factor should not be directly involved in the observed suppression of PC expression, albeit we cannot presently exclude functional defects.
In a podocyte cell line, WTIP inhibited transcriptional activation by WT1 (28) . WTIP was reported to function as a "damage sensor" for transmitting signals to WT1 to modulate gene expression. We demonstrated herein that intact WT1 and another cofactor, CBP, were associated in HGEC. This interaction was significantly impaired in a glucose-dependent manner, contributing to the observed downregulation of PC expression. Our data indicate that these partners serve as "positive regulators" of WT1 transcriptional activity in podocytes, since disruption of this interaction resulted in reduced WT1 binding to the PC gene promoter. Hence we demonstrate for the first time that, in cultured podocytes, WT1 and CBP are part of a protein complex in interplay. This complex should be at least in part responsible for maintaining the binding of WT1 to the PC gene promoter and sustaining PC gene transcription.
High glucose also results in chemical modification of cellular macromolecules which form nonenzymatically by reducing glucose, lipids, and/or certain amino acids on proteins, lipids, and nucleic acids. Cross-linked AGEs form stable cross-link structures with other proteins in the body, membrane phospholipids, DNA, and lipoproteins and also bind to AGE receptors (RAGE), which become upregulated in diabetes, indicating AGE accumulation (9, 27, 35, 39) . We have provided evidence that inhibition of AGE formation prevented the observed glucose-induced suppression of PC. Hence the presence of AG "protected" PC expression from glucose-induced silencing. In another report, Gu et. al. (12) suggested that AGEs modulate local monocyte chemoattractant protein-1 (MCP-1) expression in conditionally immortalized mouse podocytes through activation of RAGE in an NF-B-and Sp1-mediated regulation of MCP-1 transcription. -20) . The specificity of the nephrin band was evaluated after preabsorption of the anti-nephrin antibody with its specific peptide (lane 4). Blots were reprobed with an anti-tubulin antibody to verify protein loads against which the data were normalized. B: values are means Ϯ SD of 3 independent experiments analyzed by densitometric analysis using singlefactor ANOVA. Reduction of nephrin protein levels by HGEC cultured in the presence of 25 mM glucose was statistically significant compared with control cells. White bars, HGEC exposed to 5 mM glucose; shaded bar, HGEC exposed to 25 mM glucose. **P Ͻ 0.002 by ANOVA. C: real-time PCR analysis for nephrin in HGEC. Nephrin expression was measured in HGEC exposed to 5 and 25 mM glucose, continuously exposed to 25 mM and reverted to 5 mM for 6 wk, and continuously exposed to 25 mM and reverted to 5 mM for 12 wk respectively. GAPDH was used as the normalizer gene. Values are means Ϯ SD of 3 quadruplicate experiments. White bars, HGEC exposed to 5 mM glucose; shaded bars, HGEC exposed to 25 mM glucose. ***P Ͻ 0.001 by ANOVA.
In our system, several mechanisms could explain the effects of nonenzymatic glycation on PC expression. One of the proposed mechanisms by Gu et. al. (12) implicated nuclear translocation of Sp1 and subsequent Sp1-mediated regulation of transcription. However, in our model system, Sp1 nuclear protein levels do not seem to be affected in HGEC not expressing PC. Additionally, nuclear translocation of Sp1 remained unaltered. Another possibility is that AGE accumulation altered WT1 function by decreasing protein-protein interactions between WT1 and several of its cofactors. In a different report, nonenzymatic glucosylation of the transcription factor Stat5a decreased its interaction with its cofactor CBP (11) . According to this hypothesis, an explanation of our data, at least in part, could be glycation-induced impairment of the WT1-CBP association, which blocked the binding of WT1 to the relevant response sequence on the PC promoter region; hence WT1 and/or its coactivators are potential targets of AGE formation. Interestingly, the formation of AGEs is not restricted to proteins but can also occur in other biological molecules, such as nucleosides, and can damage DNA by changing its conformation (8) . Hence it could be argued that in addition to glycation-induced impairment of WT1-CBP interactions, there could be AGE-induced impairment of WT1 binding to specific DNA sequences, perhaps due to altered DNA conformation. The end result could account, at least in part, for the observed suppression of PC expression. A conformational change of DNA might persist and help explain the observed prolonged suppression of PC expression, but this hypothesis remains to be substantiated.
Furthermore, it appears that glycation-induced suppression of gene expression was relatively specific to WT1 target genes such as PC. Other surface-associated proteins of podocytes , and 18 wk, respectively. Blots were reprobed with an anti-tubulin antibody to verify protein loads against which the data were normalized. B: quantitation of PC protein content by densitometric analysis. Values are means Ϯ SD of 2 independent experiments analyzed using single-factor ANOVA. The concomitant presence of AG in the culture medium does not affect PC expression levels. Open bar, HGEC exposed to 5 mM glucose; filled bars, HGEC exposed to 5 mM glucose and 20 mM AG. C: Western blot analysis for PC expression in HGEC. Lanes 1 and 4, PC expression in cells permanently cultured in the presence of 5 (control) or 25 mM glucose levels, respectively; lanes 2, 3, 6, and 7, PC expression in HGEC continuously exposed to 5 mM glucose and subsequently reverted to 25 mM glucose and 20 mM AG simultaneously for 1, 2, 6, and 18 wk respectively; lane 5, HGEC continuously exposed to 5 mM glucose and reverted to 25 mM for 16 wk. These HGEC were subsequently cultured for another 2 wk in the presence of 25 mM glucose levels and 20 mM AG. Equal amounts of total protein were analyzed on 7.5% SDS-PAGE under reducing conditions and immunoblotted with an anti-PC antibody (3D3). Blots were stripped and reprobed with an anti-tubulin antibody to verify protein loads against which the data were normalized. D: Western blot analysis for PC expression in HGEC. Lane 1, PC expression in HGEC cultured in the presence of 5 mM glucose; lanes 2-5, HGEC continuously exposed to 5 mM glucose and reverted to 25 mM glucose for 1, 2, 6, and 18 wk, respectively. Equal amounts of total protein were analyzed on 7.5% SDS-PAGE under reducing conditions and immunoblotted with 3D3. Blots were stripped and reprobed with an anti-tubulin antibody to verify protein loads against which the data were normalized. E: quantitation of PC protein content by densitometric analysis. Values are means Ϯ SD of 6 independent experiments analyzed using single-factor ANOVA. Reduction of PC protein levels in HGEC cultured in the presence of 25 mM glucose was statistically significant compared with control cells. White bar, HGEC exposed to 5 mM glucose only; shaded bars, HGEC exposed to 5 mM glucose and reverted to 25 mM glucose; black bars, HGEC exposed to 25 mM glucose and 20 mM AG simultaneously. ***P Ͻ 0.001 by ANOVA. Reduction of PC protein levels in HGEC continusously exposed to 5 mM glucose and reverted to 25 mM only for 2, 6, and 18 wk was statistically significant compared with cells reverted to 25 and 20 mM AG for the same time points. *P Ͻ 0.05, **P Ͻ 0.001 by ANOVA. Reduction of PC protein levels in HGEC continusously exposed to 5 mM glucose and reverted to 25 mM for 16 wk and subsequently cultured for another 2 wk in the presence of 5 mM glucoses and 20 mM AG was statistically significant compared with HGEC continuously exposed to 25 and 20 mM AG at the same time for 18 wk. **P Ͻ 0.001 by ANOVA. such as ␣ 3 ␤ 1 -integrins (data not shown) and ZO-1 (a protein of tight junctions) were also decreased by high glucose, but their levels were restored when glucose levels were reverted to 5 mM. PC is a sialoprotein pivotal for the maintenance of foot processes, which are involved in permselectivity functions of podocytes. It is worth noting that nephrin, another component of HGEC which is regulated by WT1 at least in part (37) , and plays a role in permselectivity in vivo, was also decreased by high glucose in a pattern similar to PC.
In summary, then, our data substantiate that in vitro transcription of the human PC gene is dependent on unimpaired WT1-CBP interactions and not regulation by WT1 alone. Impaired WT1-CBP interactions as well as glucose-induced AGEs resulted in suppression of components of the permselectivity barrier such as PC and nephrin, which are regulated by WT1. Decreased binding of WT1-CBP to the PC promoter in vivo, at different times before and after euglycemia, remains to be substantiated.
